Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A team of researchers are looking for volunteers in the South West of England to take part in a study which will assess a new technology for detecting Parkinson’s disease at a very early stage.

One of the ways scientists are hoping to help combat Parkinson’s is by trying to find ways to detect the disease as early as possible. There is currently no means of reliable diagnosis for the disease and so the outcome of this study could prove to be of tremendous significance to patients and clinicians alike.

Parkinson’s is a progressive neurological condition that affects movement and speech.  At present there is no cure and little understanding as to why some people develop the condition. One in 500 people in the UK, or around 127,000 individuals, currently have Parkinson’s. Worldwide, it is estimated that 10-20 million people are living with the disease and this number is expected to double by 2030. Many of these cases are undiagnosed and untreated.

The technology to be assessed is called the Body Sensor Network (BSN), a system developed over the past several years by Dr Newton Howard (Nuffield Department of Surgical Sciences) and Dr John Stein (Department of Physiology, Anatomy and Genetics) at the University of Oxford, the Massachusetts Institute of Technology (MIT) and the Brain Sciences Foundation. The BSN is a system comprised of various body sensors worn on the arms and torso, accompanied by a microphone to record speech patterns and tremor.

The researchers - from Plymouth University Peninsula Schools of Medicine and Dentistry, in collaboration with the MIT and the Oxford Computational Neurosciences Lab - aim to assess the degree of accuracy with which the BSN can distinguish people with early Parkinson’s (diagnosed within the last five years) from those unaffected by the disease. In addition, the study will determine whether the system is able to reliably distinguish Parkinson’s patients from those with other neurological conditions such as Alzheimer’s disease.

Members of the research team are looking for 20 volunteers from each of these groups – a total of 60 recruits.

The study will involve a single visit to the research centre in Plymouth lasting two hours. Here, participants will be asked to perform a series of everyday tasks, such as putting on a cardigan or buttering a slice of toast while wearing the BSN system.

The study in Plymouth is being led by Dr Camille Carroll, a Consultant Neurologist and researcher at Plymouth University Peninsula Schools of Medicine and Dentistry.

She said: ‘BSN has the potential to be developed into an exciting and valuable tool for the early diagnosis of Parkinson’s. If successful, it can go on to play a vital role in improving the quality of life and care programmes for people with the condition. Early interventions show better outcomes for patients.’

Notes to editors

For more information about getting involved with this study, please call research nurse Sandra Morgan on 01752 432047.

The study is supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South West Peninsula. For further information, please visit http://clahrc-peninsula.nihr.ac.uk.

Similar stories

New reporting guidelines to bridge the gap from development to implementation in clinical artificial intelligence

Innovation Research

In a correspondence to Nature Medicine, a team of Oxford-led academics describe upcoming new guidelines to improve the reporting of early clinical stage (or first-with-human) evaluation of decision support systems driven by artificial intelligence.

Cochrane ENT awarded NIHR funding for COVID-19 project

Awards and appointments Coronavirus COVID-19 Research

Cochrane ENT at the Nuffield Department of Surgical Sciences has been awarded funding by the National Institute for Health Research (NIHR) to complete a suite of living systematic reviews investigating the effectiveness and safety of interventions to prevent and treat loss of smell after COVID-19 infection.

First peer-reviewed results of phase 3 human trials of Oxford coronavirus vaccine demonstrate efficacy

Coronavirus COVID-19 Publication Research

Today University of Oxford and AstraZeneca researchers present a pooled analysis of Phase 3 trials of a vaccine against SARS-CoV-2 across two different dose regimens, resulting in an average efficacy of 70.4%.

Applications for Oxford-Wolfson-Marriott-Patel Scholarship now open

Awards and appointments Department Research

The Nuffield Department of Surgical Sciences (NDS) are pleased to confirm that one scholarship will be available for Home (UK) and Republic of Ireland (ROI) candidates for the DPhil in Surgical Sciences, starting in Michaelmas Term 2021.

Oxford University breakthrough on global COVID-19 vaccine

Coronavirus COVID-19 Research

The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.

Transplant kidney survival rate improves with new method of transportation

Publication Research

New research by the Consortium for Organ Preservation in Europe (COPE) has found that a new method to transport donor kidneys, which uses a combination of cold perfusion with oxygen, can significantly improve transplant results, with less graft failure, better function and lower rejection of the kidney when compared to cold perfusion alone. For patients who need a kidney transplant this is a big step forward. The study, carried out in Belgium, The Netherlands and the UK, was published today in The Lancet.